Fluorescence in situ hybridization for detection of MAML2 rearrangements in oncocytic mucoepidermoid carcinomas: utility as a diagnostic test.
暂无分享,去创建一个
R. Seethala | S. Dacic | J. Hunt | J. Mchugh | E. Barnes | I. Weinreb | K. Cieply | Joaquín J. García
[1] R. Seethala,et al. A Reappraisal of the MECT1/MAML2 Translocation in Salivary Mucoepidermoid Carcinomas , 2010, The American journal of surgical pathology.
[2] Y. Hasegawa,et al. Clinicopathological significance of the CRTC3–MAML2 fusion transcript in mucoepidermoid carcinoma , 2009, Modern Pathology.
[3] C. Land,et al. Incidence of Carcinoma of the Major Salivary Glands According to the WHO Classification, 1992 to 2006: A Population-Based Study in the United States , 2009, Cancer Epidemiology, Biomarkers & Prevention.
[4] Y. Hasegawa,et al. Prognostic significance of p27Kip1, Ki-67, and CRTC1-MAML2 fusion transcript in mucoepidermoid carcinoma: a molecular and clinicopathologic study of 101 cases. , 2009, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[5] M. Luna,et al. Warthin adenocarcinoma: analysis of 2 cases of a distinct salivary neoplasm. , 2009, Annals of diagnostic pathology.
[6] R. Seethala,et al. Oncocytic Mucoepidermoid Carcinoma: Clinicopathologic Description in a Series of 12 Cases , 2009, The American journal of surgical pathology.
[7] R. Seethala. CRTC1/MAML2 Fusion Transcript in Warthin’s Tumor and Mucoepidermoid Carcinoma: Evidence for a Common Genetic Association , 2009 .
[8] Jörn Bullerdiek,et al. A new type of MAML2 fusion in mucoepidermoid carcinoma , 2008, Genes, chromosomes & cancer.
[9] T. Löning,et al. A closer look at Warthin tumors and the t(11;19). , 2008, Cancer genetics and cytogenetics.
[10] Anil V. Parwani,et al. p63 Immunohistochemistry Differentiates Salivary Gland Oncocytoma and Oncocytic Carcinoma from Metastatic Renal Cell Carcinoma , 2007, Head and neck pathology.
[11] F. Kaye,et al. CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: Implications for histogenesis and biologic behavior , 2007, Genes, chromosomes & cancer.
[12] M. Luna. Salivary Mucoepidermoid Carcinoma: Revisited , 2006, Advances in anatomic pathology.
[13] F. Enlund,et al. The MECT1-MAML2 gene fusion and benign Warthin's tumor: is the MECT1-MAML2 gene fusion specific to mucuepidermoid carcinoma? , 2006, The Journal of molecular diagnostics : JMD.
[14] Shigeo Nakamura,et al. MECT1-MAML2 Fusion Transcript Defines a Favorable Subset of Mucoepidermoid Carcinoma , 2006, Clinical Cancer Research.
[15] L. Szekely,et al. Molecular classification of mucoepidermoid carcinomas—Prognostic significance of the MECT1–MAML2 fusion oncogene , 2006, Genes, chromosomes & cancer.
[16] J. Hunt,et al. Molecular assessment of allelic loss in Warthin tumors , 2005, Modern Pathology.
[17] G. Tonon,et al. A study of MECT1-MAML2 in mucoepidermoid carcinoma and Warthin's tumor of salivary glands. , 2004, The Journal of molecular diagnostics : JMD.
[18] U. Lendahl,et al. Altered Notch signaling resulting from expression of a WAMTP1-MAML2 gene fusion in mucoepidermoid carcinomas and benign Warthin's tumors. , 2004, Experimental cell research.
[19] R. Brannon,et al. Oncocytic mucoepidermoid carcinoma of parotid gland origin. , 2003, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[20] A. Orth,et al. Identification of a family of cAMP response element-binding protein coactivators by genome-scale functional analysis in mammalian cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[21] Loren Miraglia,et al. TORCs: transducers of regulated CREB activity. , 2003, Molecular cell.
[22] G. Tonon,et al. t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway , 2003, Nature Genetics.
[23] G. Tonon,et al. t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway , 2003, Nature Genetics.
[24] J. Parry,et al. Mitochondrial DNA mutations in the parotid gland of cigarette smokers and non-smokers. , 2002, Mutation research.
[25] M. Urken,et al. Mucoepidermoid Carcinoma: A Clinicopathologic Study of 80 Patients With Special Reference to Histological Grading , 2001, The American journal of surgical pathology.
[26] K. Kashima,et al. Clonal analysis of the epithelial component of Warthin's tumor. , 2000, Human pathology.
[27] L. Medeiros,et al. Mucoepidermoid carcinoma involving Warthin tumor. A report of five cases and review of the literature. , 2000, American journal of clinical pathology.
[28] D. Skibinski,et al. Detection of damage to the mitochondrial genome in the oncocytic cells of Warthin's tumour , 2000, The Journal of pathology.
[29] P. Auclair,et al. Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria , 2000 .
[30] R. M. Huberman,et al. Oncocytic mucoepidermoid carcinoma of the salivary glands. , 1999, The American journal of surgical pathology.
[31] G. Ellis,et al. Mucoepidermoid carcinoma of the major salivary glands , 1998, Cancer.
[32] H. Gustafsson,et al. Recurrent rearrangements of 11q14-22 in mucoepidermoid carcinoma. , 1994, Cancer genetics and cytogenetics.
[33] P. Auclair. Tumor-associated lymphoid proliferation in the parotid gland. A potential diagnostic pitfall. , 1994, Oral surgery, oral medicine, and oral pathology.
[34] R. Spiro,et al. Mucoepidermoid carcinoma of salivary gland origin , 1978 .
[35] R. Spiro,et al. Mucoepidermoid carcinoma of salivary gland origin. A clinicopathologic study of 367 cases. , 1978, American journal of surgery.
[36] A. French,et al. Mucoepidermoid tumors of salivary glands , 1963, Cancer.
[37] F. W. Foote,et al. MUCO‐EPIDERMOID TUMORS OF SALIVARY GLANDS , 1945, Annals of surgery.